Advertisement
Antibodies may keep the HIV virus in check and one day allow patients to stop taking antiretroviral drugs

HIV Antibody VRC01 Shows Promise in Early Trials

0
Two trials suggest approach might make it possible for patients to discontinue antiretroviral meds
Five strategies can be employed by physicians in order to help reduce the risk of lawsuits

Five Strategies Can Reduce Risk of Medical Lawsuits

0
Strategies include documenting everything, being transparent with patients, showing empathy
In the Nov. 4 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report

Recommendations Updated for Meningococcal Vaccine in HIV

0
All HIV+ individuals should receive meningococcal conjugate vaccine (serogroups A, C, W, and Y)
Ocular syphilis has been identified in jurisdictions in the United States

Ocular Syphilis Cases May Be Increasing in United States

0
Among total syphilis surveillance cases in eight jurisdictions, 0.65 percent indicated ocular symptoms
Community pharmacists are well suited to provide clinical preventive services

Community Pharmacists Play Role in Providing Preventive Care

0
Report highlights role in folic acid education, tobacco use cessation, screening for osteoporosis, HIV
For HIV-infected pregnant women

Maternal, Neonatal Adverse Events Up With Antenatal ART

0
But antiretroviral therapy also linked to significantly lower rates of early HIV transmission

October 2016 Briefing – HIV & AIDS

0
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2016. This roundup includes...
Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014

Few Changes in Employer-Sponsored Insurance 2013-2014

0
Only 3.5 percent of employers dropped coverage and 1.1 percent added coverage from 2013 to 2014
In an article published in Medical Economics

Useful Tips Offered for Addressing Negative Patient Reviews

0
Doctors should respond quickly, validate patient complaints, demonstrate willingness to take action
The intravenous drug ibalizumab might revolutionize the treatment of HIV patients who don't respond to existing drugs

IDSA: Experimental Rx May Be Option in Drug-Resistant HIV

0
'This is potentially a lifesaving therapy,' researcher says